25 results
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
full power and authority to adopt, amend, terminate, and administer our equity award, pension, and profit sharing plans, incentive plans, bonus plans … provided by our independent compensation consultant.
Performance Bonus (at-risk cash)
Motivates and rewards for attaining rigorous annual corporate
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
plans, bonus plans, executive benefit plans, stock purchase plans, deferred compensation plans and other similar programs;
when required, reviewing … by our independent compensation consultant.
Performance Bonus (at-risk cash)
Motivates and rewards for attaining rigorous annual corporate performance
10-K
2023 FY
EX-10.13
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
standard payroll practices (the “Base Salary”).
2.2 Bonus.
(a) During Employment. Executive shall be eligible to receive an annual performance bonus … (the “Annual Bonus”) with an annual target of 40% (the “Target Percentage”) of Executive’s then-current Base Salary (the “Target Bonus”). The Annual
10-K
2023 FY
EX-10.14
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
be eligible to receive an annual performance bonus (the “Annual Bonus”) with an annual target of 40% (the “Target Percentage”) of your then-current Base … Salary (the “Target Bonus”). The Annual Bonus will be based upon the assessment of the Board of Directors (the “Board”) of Immunocore Holdings Plc
10-K
2023 FY
EX-10.12
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
in accordance with the Company’s standard payroll practices (the “Base Salary”).
2.2 Bonus.
(a) During Employment. Executive shall be eligible … to receive an annual performance bonus (the “Annual Bonus”) with an annual target of 40% (the “Target Percentage”) of Executive’s then-current Base Salary
10-K
amojdwab
28 Feb 24
Annual report
7:33am
6-K/A
EX-99.1
bnhrxcp6eeuz65ts 48
18 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
4:17pm
6-K
EX-99.1
hw8m9gu4
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.1
unwzd7r
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
ggjbfj bsma
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.2
ou4t7o50e25 ra5
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
EX-99.1
cjvagvt2
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
20-F
EX-1.1
dfrxn eygo86k929tuz
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-4.20
3xwquy6
25 Mar 21
Annual report (foreign)
7:01am
20-F
rcjvyl3y08 ehgtuaf
25 Mar 21
Annual report (foreign)
7:01am
424B4
bposv jdcirug5eh28
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
8whu1dp 3nuwx1rd2qe
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
EX-1.1
dtp1kn85
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
q449l229cm90vroap7
1 Feb 21
Registration statement (foreign) (amended)
6:21am